1. Risk depends on the itinerary and the traveler

At elevation, lower barometric pressure reduces the oxygen available with each breath. Acute mountain sickness (AMS), high-altitude cerebral edema (HACE), and high-altitude pulmonary edema (HAPE) are possible, but no single elevation predicts illness for everyone. Arrival elevation, how quickly sleeping elevation increases, prior acclimatization, and personal health all matter. A rapid trip from low elevation to above 2,750 m (9,000 ft), or a schedule that raises sleeping elevation quickly, can increase risk.

Headache, nausea, reduced appetite, and fatigue can occur with AMS, but they can also have other causes. Do not use a symptom list to make a definitive diagnosis. Anyone with altitude illness should stop ascending and should not sleep higher while symptomatic. Worsening symptoms, especially at rest, call for descent and medical assessment. Travelers with heart or lung conditions, pregnancy, or medicines that could affect their plans should discuss the actual itinerary with a clinician before departure.

2. Recognize HACE and HAPE as emergencies

Confusion, unusual drowsiness, loss of coordination, or difficulty walking can signal HACE. Breathlessness at rest, worsening shortness of breath, cough, or marked weakness can signal HAPE. Do not wait for late signs such as blue lips or frothy sputum. Either condition can become life-threatening, and field diagnosis can be difficult.

Stay with the ill person and contact local emergency or rescue services promptly. Move or arrange movement to a lower elevation as soon as it can be done safely, following rescue-team instructions. Descent is central to treatment for suspected HACE or HAPE. Supplemental oxygen or a portable hyperbaric chamber can be useful when available and used under an appropriate medical or trained-rescue plan, but they are not universal substitutes for descent and evaluation. Fixed oxygen-flow rates, descent distances, and drug doses should not be presented as instructions for every traveler.

3. Reduce risk by ascending gradually

When practical, avoid going from low elevation to above 2,750 m (9,000 ft) in one day. CDC traveler guidance suggests spending 2–3 nights around 2,450–2,750 m (8,000–9,000 ft) before going higher when the itinerary allows. Above 3,000 m (9,850 ft), guidance suggests increasing sleeping elevation by no more than about 500 m (1,600 ft) per day and adding an acclimatization day for every 1,000 m of sleeping-elevation gain. These are planning recommendations, not a guarantee or a personalized prescription. Day trips higher with a return to a lower sleeping elevation can also help.

During the first 48 hours at elevation, avoid strenuous exertion and alcohol and pay attention to how you feel. Preventive medicine may be appropriate for some itineraries, but the choice depends on medical history, contraindications, interactions, and the planned ascent. Do not start a drug or copy a dose from an article without a clinician’s advice. Medication must not be used to mask symptoms so that ascent can continue.

4. Prepare communication and evacuation options

Pulse oximetry can assist clinical assessment, but readings vary with elevation and individual factors. A single number cannot rule out HACE or HAPE or justify delaying descent.

Before a remote trip, identify emergency contacts, communication coverage, descent routes, and weather contingencies, and share them with the group. Oxygen, medicines, and portable chambers are adjuncts for people who know how to use them within a care plan. They do not replace evacuation and assessment. When the diagnosis or next step is uncertain, contact local rescue professionals or a medical service rather than relying on a universal field protocol.

Sources and references: CDC Yellow Book: High-Elevation Travel and Altitude Illness / Wilderness Medical Society Clinical Practice Guidelines: 2024 Update